High Performance Low Price Infusion Syringe Pump… Available from Dorton Analytical - the Legato 100 Syringe Pump is a new single syringe infusion only pump with a touch screen interface. The Legato 100 offers a wide flow rate range (1.28 pl/min to 88.28 ml/min), accuracy of +/-0.5% and reproducibility of +/- 0.05% making it the [...]

Bishops Stortford, United Kingdom - Cutting edge informatics company Dotmatics Limited (Dotmatics) were selected by Almirall, the international pharmaceutical company located in Spain, to provide a range of drug discovery informatics solutions. Dr. Johannes Floeckner, Head of R&D Information Systems at Almirall said “We are very pleased to be working with Dotmatics. After we evaluated [...]

Madison, WI - Roche NimbleGen (SIX: RO, ROG; OTCQX: RHHBY) is pleased to announce that São Paulo-based genomic services provider Helixxa has officially joined the Roche NimbleGen Certified Service Provider (CSP) Program. Helixxa has been certified to process customer samples for NimbleGen Gene Expression arrays in their lab outside of São Paulo. Helixxa is the [...]

ALAMEDA, Calif. - BioTime, Inc. (NYSE Amex:BTX) today announced that in the last 18 months it has received cumulative total proceeds of $24,174,733 from exercises of warrants that expired November 1, 2010. A remaining 24,976 common share purchase warrants expired unexercised. BioTime now has approximately $32 million of cash on hand on a consolidated basis. [...]

Madison, WI - Cellular Dynamics International, Inc. (CDI) announced today that it has been awarded a total of $977,915 for investments in four qualifying therapeutic discovery projects. CDI, the world’s largest producer of human tissue cells for drug discovery and safety, will use the grant money to advance the development of its programs in hepatocytes, [...]

Madison, WI (USA) and Naarden, The Netherlands BioSystem Development, creators of AssayMAP® high?throughput micro?chromatography technology and BAC BV, the leading provider of antibody?based affinity purification technology, announce a collaboration to bring state?of?the?art high affinity ligands to the AssayMAP high?throughput micro?chromatography platform. This collaboration marks an essential objective toward growing a family of high?throughput tools for micro?scale purification and quantification of monoclonal antibodies.    The aim of the collaboration is to develop new tools and innovative solutions to purify and precisely quantify biotherapeutic atibodies in complex samples (such as cell culture supernatant and serum), a critical step in the manufacture of new biotherapeutics.  BAC will contribute their proprietary CaptureSelect® Antibody Toolbox affinity ligands, based on Camelid single?chain antibody fragments. The unique properties of these ligands, such as high selectivity and distinctive binding characteristics, provide increased flexibility in the purification process of any antibody format. BAC CEO, Dr. Laurens Sierkstra comments, “By combining BAC’s solutions for antibody purification with the AssayMAP high?throughput chromatography platform we enable researchers to optimize production and purification processes for their lead molecles early in the development process.”   BioSystem Development contributes the AssayMAP micro?chromatography platform, a patented cartridge separation system bridging complex chemistries with high?throughput, high?precision environments. BSD’s Founder and CEO Scott Fulton stated, “This collaboration provides a scalable format with the CaptureSelect purification technology. We are starting with the CaptureSelect Fab kappa and Human Fc ligands to enable parallel, high?throughput purification and analysis of antibodies and fusions from any source, bringing this technology to bioprocess research and development.”

CARLSBAD, Calif. - Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative life science solutions, is hosting the 2nd Annual Cell Therapy Industry Summit November 3-5 at the Sheraton Carlsbad Resort and Spa in Carlsbad, CA. Senior executives will discuss achievements made in cell therapy and regenerative medicine in addressing economic, political and regulatory challenges, including [...]

Gaithersburg, Md. - BGI, the largest genomics organization in the world, and OpGen, Inc., a commercial phase genomics company and exclusive provider of Optical Mapping Technology, announced their joint effort to expand the use of Optical Mapping for de novo sequence finishing in human, plant and animal genomes. BGI and OpGen have successfully completed a [...]

CARLSBAD, Calif - Life Technologies Corporation, a provider of innovative life science solutions, today announced the introduction of its first commercially available kit to facilitate digital PCR on the OpenArray® Real-Time qPCR System. The offering enables scientists to apply this novel technology to a broad range of nucleic acid detection studies and provides more accurate [...]

CENTER VALLEY, Pa. - Olympus cellSens* software, leading the industry with its easy-to-use platform for capturing and analyzing microscope images, has just become even better. The latest version of the software, cellSens version 1.4, will control all the automated functions and components for the company's recently introduced BX3® series motorized microscopes. Two motorized BX3 microscope [...]